Point-of-Care Manufacturing: Does Improving Patient Access Increase their Risks?
Wednesday, May 29, 2024 09:15 AM - 10:15 AM
Room 202-204
Roundtable
Organized by: ISCT Early Stage Professionals Committee
Moderator
Improve on existing models to circumvent risks associated with decentralized manufacturing.
Key Learning Objectives
1. Better understand different jurisdictional innovative models for access to cell and gene therapies (with emphasis on CAR T cell therapy)
2. Understand regulatory hurdles across jurisdictions
3. Dispel myths regarding academically-led models, and describe how processes are undertaken to ensure safe and effective products
4. Understand the complementary nature in which different models can work together to achieve a unified goals of providing access to potentially curative therapies to our respective patient communities
Moderator
- John Bell, PhD, FRSC, FCAHS, BioCanRx / Ottawa Hospital Research Institute/University of Ottawa, Canada
- Manel Juan, MD, PhD, School of Medicine, University de Barcelonas, Spain
- Natasha Kekre, MD, MPH, FRCPC, Ottawa Hospital Research Institute, Canada
- Rimas J. Orentas, PhD, Caring Cross Inc., United States
Improve on existing models to circumvent risks associated with decentralized manufacturing.
Key Learning Objectives
1. Better understand different jurisdictional innovative models for access to cell and gene therapies (with emphasis on CAR T cell therapy)
2. Understand regulatory hurdles across jurisdictions
3. Dispel myths regarding academically-led models, and describe how processes are undertaken to ensure safe and effective products
4. Understand the complementary nature in which different models can work together to achieve a unified goals of providing access to potentially curative therapies to our respective patient communities
MANUEL JUAN OTERO
Head of Immunology Department
Hospital Clínic de Barcelona Plataforma HSJD-HCB - UB
Panelist
Head of Immunology Department
Hospital Clínic de Barcelona Plataforma HSJD-HCB - UB
Panelist
Natasha Kekre
Hematologist, Transplant and Cellular Therapy Program
Ottawa Hospital Research Institute
Panelist
Hematologist, Transplant and Cellular Therapy Program
Ottawa Hospital Research Institute
Panelist